PART 15Consequential Amendments
Amendment of the Medicines for Human Use (Clinical Trials) Regulations 200458
1
The Medicines for Human Use (Clinical Trials) Regulations 200420 are amended as follows.
2
In regulation—
a
17(2)(b)(ii) (request for authorisation to conduct a clinical trial),
b
24(10) (amendments by the sponsor),
c
38(3)(b) (application for manufacturing authorisation),
d
44(8) (variation of manufacturing authorisation),
for “Medicines (Products for Human Use) (Fees) Regulations 2012” substitute “Medicines (Products for Human Use) (Fees) Regulations 2013”.